Answers are grounded in this paper and cite their sources.
Prediction tool estimates lung cancer risk in Hodgkin lymphoma survivors, suggesting a new clinical utility.
We developed a well-calibrated prediction tool that estimates long-term risk of LC with good discrimination based on patient characteristics and MLD, allowing application in HL survivors and contemporary HL patients.
No takes yet. Share an insight, caveat, or question.
Roshani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: